Building a Semantic Interoperability Framework for Care and Research in Fibromuscular Dysplasia

UNLABELLED Identifying patients with Fibromuscular Dysplasia (FMD) at the international level will have considerable value for understanding the epidemiology, clinical manifestations and susceptible genes in this arterial disease, but also for identifying eligible patients in clinical trials or cohorts. We present a two-step methodology to create a general semantic interoperability framework allowing access and comparison of distributed data over various nations, languages, formats and databases. METHODS The first step is to develop a pivot multidimensional model based on a core dataset to harmonize existing heterogeneous data sources. The second step is to align the model to additional data, semantically related to FMD and collected currently in various registries. We present the results of the first step that has been fully completed with the validation and implementation of the model in a dedicated information system (SIR-FMD). We discuss the current achievements for step 2 and the extensibility of the methodology in the context of other rare diseases.

[1]  Marie-Christine Jaulent,et al.  Formalizing Mappings to Optimize Automated Schema Alignment: Application to Rare Diseases , 2014, MIE.

[2]  Jean Charlet,et al.  Integrating the Human Phenotype Ontology into HeTOP Terminology-Ontology Server , 2013, MedInfo.

[3]  Erhard Rahm,et al.  A survey of approaches to automatic schema matching , 2001, The VLDB Journal.

[4]  K. Eagle,et al.  The United States Registry for Fibromuscular Dysplasia: Results in the First 447 Patients , 2012, Circulation.

[5]  Vasa Curcin,et al.  A unified structural/terminological interoperability framework based on LexEVS: application to TRANSFoRm , 2013, J. Am. Medical Informatics Assoc..

[6]  Christel Daniel-Le Bozec,et al.  Using electronic health records for clinical research: The case of the EHR4CR project , 2015, J. Biomed. Informatics.

[7]  Christopher B. Forrest,et al.  The case for a global rare-diseases registry , 2011, The Lancet.

[8]  P. D. de Leeuw,et al.  European consensus on the diagnosis and management of fibromuscular dysplasia. , 2014, Journal of hypertension.

[9]  Stéphane Moreau,et al.  MetaSurv: Web-Platform Generator for the Monitoring of Health Indicators and Interactive Geographical Information System , 2005, MIE.

[10]  Dipak Kalra,et al.  Improving EHR Semantic Interoperability: Future Vision and Challenges , 2014, MIE.

[11]  Christel Daniel-Le Bozec,et al.  An Ontological Approach for the Exploitation of Clinical Data , 2013, MedInfo.

[12]  X. Jeunemaître,et al.  Association Between 2 Angiographic Subtypes of Renal Artery Fibromuscular Dysplasia and Clinical Characteristics , 2012, Circulation.

[13]  Heather Kincaid,et al.  Development of common data elements: the experience of and recommendations from the early detection research network , 2003, Int. J. Medical Informatics.

[14]  Paul Landais,et al.  A methodology for a minimum data set for rare diseases to support national centers of excellence for healthcare and research , 2015, J. Am. Medical Informatics Assoc..

[15]  Christian Lovis,et al.  DebugIT for Patient Safety - Improving the Treatment with Antibiotics through Multimedia Data Mining of Heterogeneous Clinical Data , 2008, MIE.

[16]  H. Lehnert,et al.  Phaeochromocytoma, new genes and screening strategies , 2006, Clinical endocrinology.